Cold Spring Harbor Laboratory Professor Adrian Krainer has been awarded the 2019 Peter Speiser Award.
The Institute of Pharmaceutical Sciences of ETH Zurich confers the Peter Speiser award to scientists who contributed greatly to the progress of pharmaceutical sciences. Krainer is being honored for his work in RNA splicing and for developing nusinersen (Spinraza®), a treatment for the neurodegenerative disease spinal muscular atrophy (SMA). Krainer was honored at the awards ceremony in Zurich on November 20th.
“I’m very grateful for this prestigious award in the area of pharmacology, recognizing the significance and impact of Spinraza®, the first approved therapy for SMA and first approved splicing-corrective therapy.” Krainer said. “I thank the members of my lab for their dedication, as well as our collaborators at Ionis and Biogen, clinical-trial teams, and the SMA families.”